Nomura Holdings’s Core Laboratories CLB Stock Holding History

Nomura Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,281	Closed	-$521K	–	1528
2017 Q3	$521K	Buy	5,281 +1,083	+26%	+$105K	﹤0.01%	1243
2017 Q2	$426K	Buy	+4,198	New	+$453K	﹤0.01%	1268
2016 Q1	–	Sell	-2,124	Closed	-$232K	–	1618
2015 Q4	$232K	Sell	2,124 -334	-14%	-$38.2K	﹤0.01%	1492
2015 Q3	$245K	Sell	2,458 -22,890	-90%	-$2.49M	﹤0.01%	1293
2015 Q2	$2.9M	Buy	+25,348	New	+$3.07M	0.01%	648
2014 Q4	–	Sell	-22,835	Closed	-$3.35M	–	2337
2014 Q3	$3.35M	Buy	22,835 +20,238	+779%	+$3.12M	0.01%	864
2014 Q2	$432K	Buy	2,597 +1,010	+64%	+$180K	﹤0.01%	1874
2014 Q1	$315K	Buy	+1,587	New	+$300K	﹤0.01%	2051

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Nomura Holdings's CLB Position: Q4 2017 in Review

Nomura Holdings sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 5,281 shares — an estimated $521K sold.

Nomura Holdings first reported a position in CLB in Q1 2014 and held it in 8 quarters. The position peaked at $3.35M in Q3 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Nomura Holdings reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
Nomura Holdings sold 5,281 Core Laboratories shares in Q4 2017, an estimated $521K.
Nomura Holdings first reported a position in Core Laboratories in Q1 2014 and held it in 8 quarters.
Nomura Holdings's Core Laboratories position peaked at $3.35M in Q3 2014.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Nomura Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.